About Ciprofloxacin Hydrochloride API
Therapeutic CategoryAnti-Infective
CAS Number
86393-32-0
API Technology
Synthetic
Dose Form
Oral Solids
Dr Reddy's Development Status
Available
Mechanism of Action
The bactericidal action of ciprofloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV (both Type II topoisomerases), which are required for bacterial DNA replication, transcription, repair, and recombination.
Indication
CIPRO is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated:
• Skin and Skin Structure Infections
• Bone and Joint Infections
• Complicated Intra-Abdominal Infections
• Infectious Diarrhea
• Typhoid Fever (Enteric Fever)
• Uncomplicated Cervical and Urethral Gonorrhea
• Inhalational Anthrax post-exposure in adult and pediatric patients
• Plague in adult and pediatric patients
• Chronic Bacterial Prostatitis
• Lower Respiratory Tract Infections
o Acute Exacerbation of Chronic Bronchitis
• Urinary Tract Infections
o Urinary Tract Infections (UTI)
o Acute Uncomplicated Cystitis
o Complicated UTI and Pyelonephritis in Pediatric Patients
• Acute Sinusitis
Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of CIPRO and other antibacterial drugs, CIPRO should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria
Related APIs
Ciprofloxacin Hydrochloride
Anti-Infective
Gatifloxacin (Anhydrous)
Anti-Infective
Levofloxacin Hemihydrate
Anti-Infective
Moxifloxacin Hydrochloride (Anhydrous)
Anti-Infective
Permethrin
Anti-Infective
Posaconazole
Anti-Infective
Terbinafine Hydrochloride
Anti-Infective
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.